Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Naropin (Ropivacaine HCI) Injection
Company:  AstraZeneca L.P.
Application No.:  020533S002
Approval Date: 11/02/2000


Date created: June 282004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.